spacer
home > pmps > autumn 2017 > reduce, reuse, recycle
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Reduce, Reuse, Recycle

Faced with rising volumes of regulations, such as new Good Distribution Practices, pharmaceutical laboratories and their partners (clinical trial and logistics operators or specialists in the last mile of the cold chain) are looking for more efficient packaging solutions. Product ranges require temperature-controlled transportation, and the demand in this area is continually on the rise.

Tight Budgetary Restrictions

All these imperatives – and tight budget controls, in particular – are prompting purchasing and logistics departments in the cold chain to permanently optimise their transport costs. One upshot of this trend has been the shift from active to passive systems observed in recent years.

Passive isothermal packaging is cheaper, lighter and more flexible and currently offers such high standards of performance that the use of active isothermal packaging no longer makes any economic sense for certain destinations.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Yann Martin is the global sales director for EMBALL'ISO Group and its eight productions sites worldwide. He works with its team to support the pharma shippers and logistics providers to implement global temperature-controlled solutions. Over the past few years, Yann has driven the introduction of new business models in the company and market, such as rental, reverse logistics and ready-to-use services. Before taking these responsibilities, he worked on the technical side as Manager of the validation department and product design department. Yann holds a master’s degree in engineering from Polytech’Savoie, France. 
spacer
Yann Martin
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

POP TEST ADDRESSES THE PROBLEM OF UNRELIABLE DATA FROM CONTINUOUS GLUCOSE MONITORS

A major insight relating to the unreliability of data from continuous glucose monitors was published in the Nature journal, “Scientific Reports”, by Neil Theise, MD., the Lead Scientist of Pop Test, LLC and colleagues. The discovery of the “Interstitium”, a newfound human organ, by Dr. Theise and his collaborators, can be viewed by using the link https://www.nature.com/articles/s41598-018-23062-6 Continual glucose monitoring via an indwelling cutaneous needle measuring glucose in interstitial fluid (now identified to be in the “interstitium”) has been a game changer in the treatment of type 1 diabetes mellitus because of its accuracy. However, the needles used to collect this glucose containing fluid often fail in as little as a week. Despite the reliance on fluid from this space, the microanatomy of the interstitium has never been defined. The sensors currently in use were developed with the presumption of interstitial fluid being located somewhere in the sub-epidermal layers of the skin, but the actual anatomy relating to needle placement was always unclear.
More info >>

White Papers

Tabletability, Compactability, and Compressibilty: What’s the Difference?

Natoli Engineering Company, Inc.

To patients and consumers, tablets are a simple and convenient dosage form. But the science behind compressing a block of particles or granules into a single tablet can be complicated. That’s where common compression studies can help. This article explains how to develop tabletability, compactibility, and compressibility profiles.
More info >>

 
Industry Events

SAPHEX 2018

1-2 November 2018, Gallagher Convention Centre, Midrand, South Africa

The SAPHEX exhibition and conference is now established as the “go-to” networking and business event for anyone working in the South African pharmaceutical manufacturing industry.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement